iBio Inc. (NYSE AMERICAN: IBIO)
$2.12
-0.0300 ( -1.40% ) 22.6K
iBio Inc is a part of the healthcare sector. Its main business is commercialized technologies and product candidates and manufacturing services to clients and collaborators. Its main area of business is plant-based protein expression technologies for vaccines and therapeutic proteins and developing and commercializing select biopharmaceutical product candidates. Its products are used to combat various areas such as fibrotic diseases, cancers, and infectious diseases. The company operates in two segments: Biopharmaceuticals and Bioprocessing activities, conducted within iBio, Inc. and CDMO segment, conducted within iBio CDMO.
Market Data
Open
$2.12
Previous close
$2.15
Volume
22.6K
Market cap
$18.97M
Day range
$2.11 - $2.27
52 week range
$1.02 - $15.99
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 14 | Sep 27, 2023 |
8-k | 8K-related | 18 | Sep 21, 2023 |
4 | Insider transactions | 1 | Aug 30, 2023 |
4 | Insider transactions | 1 | Aug 24, 2023 |
4 | Insider transactions | 1 | Aug 24, 2023 |
8-k | 8K-related | 12 | Aug 07, 2023 |
8-k | 8K-related | 14 | Aug 04, 2023 |
4 | Insider transactions | 1 | Jul 28, 2023 |
4 | Insider transactions | 1 | Jul 13, 2023 |
8-k | 8K-related | 61 | Jul 10, 2023 |